Literature DB >> 33794072

Corrigendum to: LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway.

.   

Abstract

Entities:  

Year:  2021        PMID: 33794072      PMCID: PMC8016117          DOI: 10.1002/2211-5463.13116

Source DB:  PubMed          Journal:  FEBS Open Bio        ISSN: 2211-5463            Impact factor:   2.693


× No keyword cloud information.
The affiliation of the corresponding author of the paper by Jiang et al. [1] was incomplete. The full affiliation is provided here: Nianzeng Xing Department of Urology, Beijing Chao‐Yang Hospital, Capital Medical University, Beijing, 100020, China Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China Correspondence to: Nianzeng Xing, Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. Tel: +010 67781331 E‐mail: nianzeng168@163.com
  1 in total

1.  LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway.

Authors:  Tao Jiang; Xinxing Lu; Feiya Yang; Mingshuai Wang; Hua Yang; Nianzeng Xing
Journal:  FEBS Open Bio       Date:  2020-09-16       Impact factor: 2.792

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.